All Posts
  • Videos
1 min read

Scaling Smarter: a Case Study in Overcoming Cell Therapy Manufacturing & Regulatory Hurdles

On this page

Share

Cell & Gene Therapy Insights Webinar titled “Scaling Smarter: a case study in overcoming cell therapy manufacturing and regulatory hurdles”

Related Articles

Explore posts connected to this topic

View Resources

Tr1X to Present New Clinical and Preclinical Data on Engineered Tr1 Treg Cell Therapies at ASGCT 2026

SAN DIEGO–(BUSINESS WIRE)–Tr1X, Inc., a clinical-stage autoimmune and inflammatory disease company developing Type 1 regulatory T (Tr1) cell therapies, today...

  • Press Releases

Bag of Tr1Xs: Off-the-Shelf Type 1 Treg Shows Phase I Promise for GvHD

In a clinical first, Tr1X Bio showed immune reconstitution and

  • Interviews

Tr1X Presents First Clinical Data Demonstrating Proof of Safety and Proof of Mechanism With Allogeneic Off-the-Shelf Tr1 Regulatory T Cell Therapy TRX103

First clinical data from Phase 1 dose-escalation study in patients

  • Press Releases

SAN DIEGO–(BUSINESS WIRE)–Tr1X, Inc., a clinical-stage autoimmune and inflammatory disease

  • Press Releases

In a clinical first, Tr1X Bio showed immune reconstitution and

  • Interviews

First clinical data from Phase 1 dose-escalation study in patients

  • Press Releases